Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas.
about
The dual role of complement in cancer and its implication in anti-tumor therapySensitivity of human pleural mesothelioma to oncolytic measles virus depends on defects of the type I interferon response.Preclinical Safety Studies of Enadenotucirev, a Chimeric Group B Human-Specific Oncolytic AdenovirusCombined yeast {beta}-glucan and antitumor monoclonal antibody therapy requires C5a-mediated neutrophil chemotaxis via regulation of decay-accelerating factor CD55Novel vectors for in vivo gene delivery to vascular tissue.Upregulated expression of complement inhibitory proteins on bladder cancer cells and anti-MUC1 antibody immune selection.Modulation of protective T cell immunity by complement inhibitor expression on tumor cells.Head and neck tumour immunology: basic concepts and new clinical implications.Protein engineering to target complement evasion in cancer.Antitumor Virotherapy by Attenuated Measles Virus (MV).Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.Complement activation product C4d in oral and oropharyngeal squamous cell carcinoma.
P2860
Q26738682-7295A22A-EEE7-4C15-BF09-84510E2FAFD2Q27340224-5F58328E-C4D5-4E21-AA9A-3C5704B92706Q33633287-58953420-1800-43F9-B8EB-C6D9EE0AE1D7Q35914730-E520D50F-C493-45F2-81B8-5197B993481BQ36842711-11FCE1B7-1486-4465-9860-7CFA84C5544EQ37189823-C8D0DE78-0ED2-4B6E-AC8F-E84352346874Q37189831-2AC77E7A-5802-4F3D-8C16-FA921C56B31EQ37257773-411FACBF-E412-4408-9295-EE1EB1BA2D7EQ38163242-7EBD74BA-56D1-4246-B3FD-9AA59CC0E20AQ38212137-505D45F4-1825-4486-ACA7-7C4EBB803827Q39444656-7EB649AA-ED94-4D19-B3CD-F95313D6E5ADQ39889523-333397BF-B077-4F98-8712-20793B8EC11BQ53385070-406BDD99-4437-42B6-9041-55D3EEB26E78
P2860
Expression of complement restriction factors (CD46, CD55 & CD59) in head and neck squamous cell carcinomas.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Expression of complement restr ...... neck squamous cell carcinomas.
@ast
Expression of complement restr ...... neck squamous cell carcinomas.
@en
Expression of complement restr ...... neck squamous cell carcinomas.
@nl
type
label
Expression of complement restr ...... neck squamous cell carcinomas.
@ast
Expression of complement restr ...... neck squamous cell carcinomas.
@en
Expression of complement restr ...... neck squamous cell carcinomas.
@nl
prefLabel
Expression of complement restr ...... neck squamous cell carcinomas.
@ast
Expression of complement restr ...... neck squamous cell carcinomas.
@en
Expression of complement restr ...... neck squamous cell carcinomas.
@nl
P2860
P1476
Expression of complement restr ...... neck squamous cell carcinomas.
@en
P2093
Charles Shuler
Naren M H Ravindranath
P2860
P304
P356
10.1111/J.1600-0714.2006.00466.X
P577
2006-10-01T00:00:00Z